These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35592692)

  • 1. A pragmatic dementia risk score for patients with mild cognitive impairment in a memory clinic population: Development and validation of a dementia risk score using routinely collected data.
    Wang M; Sajobi TT; Ismail Z; Seitz D; Chekouo T; Forkert ND; Fischer K; Mackie A; Pearson D; Patry D; Cieslak A; Menon B; Barber P; McLane B; Granger R; Hogan DB; Smith EE;
    Alzheimers Dement (N Y); 2022; 8(1):e12301. PubMed ID: 35592692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating expert knowledge for dementia risk prediction in individuals with mild cognitive impairment (MCI): a study protocol.
    Wang M; Smith EE; Forkert ND; Chekouo T; Ismail Z; Ganesh A; Sajobi T
    BMJ Open; 2021 Nov; 11(11):e051185. PubMed ID: 34764172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
    Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
    Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
    PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
    Song S; Asken B; Armstrong MJ; Yang Y; Li Z;
    J Alzheimers Dis; 2023; 95(2):535-548. PubMed ID: 37545237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012883. PubMed ID: 29164600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
    Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW;
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elicited clinician knowledge did not improve dementia risk prediction in individuals with mild cognitive impairment.
    Wang M; Chekouo T; Ismail Z; Forkert ND; Hogan DB; Ganesh A; Camicioli R; Seitz D; Borrie MJ; Hsiung GR; Masellis M; Moorhouse P; Tartaglia C; Smith EE; Sajobi TT;
    J Clin Epidemiol; 2023 Jun; 158():111-118. PubMed ID: 36931477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice.
    Lee JH; Byun MS; Yi D; Sohn BK; Jeon SY; Lee Y; Lee JY; Kim YK; Lee YS; Lee DY
    Front Aging Neurosci; 2018; 10():309. PubMed ID: 30337868
    [No Abstract]   [Full Text] [Related]  

  • 15. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Chen Y; Qian X; Zhang Y; Su W; Huang Y; Wang X; Chen X; Zhao E; Han L; Ma Y
    Front Aging Neurosci; 2022; 14():840386. PubMed ID: 35493941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.
    van Maurik IS; Vos SJ; Bos I; Bouwman FH; Teunissen CE; Scheltens P; Barkhof F; Frolich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Frisoni GB; Spiru L; Freund-Levi Y; Wallin AK; Hampel H; Soininen H; Tsolaki M; Verhey F; Kłoszewska I; Mecocci P; Vellas B; Lovestone S; Galluzzi S; Herukka SK; Santana I; Baldeiras I; de Mendonça A; Silva D; Chetelat G; Egret S; Palmqvist S; Hansson O; Visser PJ; Berkhof J; van der Flier WM;
    Lancet Neurol; 2019 Nov; 18(11):1034-1044. PubMed ID: 31526625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.